Kardiak

The Finecare™ BNP Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of Brain Natriuretic Peptides (BNP) in human whole blood or plasma. This test is used as an aid to predict the risk of heart failure.

The Finecare™ CK-MB Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of Creatine Kinase-MB (CK-MB) in human whole blood, serum or plasma. This test is used as an aid to assist in the diagnosis of acute myocardial infarction (AMI).

The Finecare™ cTn I/NT-proBNP Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of cardiac Troponin I (cTn I) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) in human whole blood, serum or plasma. This test is used as an aid to assist in the diagnosis of myocardial infarction and suspected congestive heart failure.

The Finecare™ cTn I Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of cardiac troponin I (cTn I) in human whole blood, serum or plasma. This test is used as an aid to assist in the diagnosis of acute myocardial infarction (AMI).

The Finecare™ One Step cTn I/CK-MB/Myo Rapid Quantitative Test a fluorescence immunoassay to be used along with Finecare™ FIA System for quantitative determination of cardiac Troponin I (cTn I), MB Isoenzyme of Creatine Kinase (CK-MB) and Myoglobin (Myo) in human whole blood, serum or plasma. The test is used as an aid to the diagnosis of myocardial infarction.

Finecare™ H-FABP Rapid Quantitative Test is a fluorescence immunoassay for quantitative measurement of Heart-type Fatty Acid Binding Protein (H-FABP) in human whole blood, serum or plasma. It is used for diagnosis of myocardial infarction.With original qualify control.

hsCRP is a sensitive index to distinguish the low level inflammatory state, which can be used as an auxiliary means for risk identification of cardiovascular disease. The serum CRP level is closely related to the occurrence, severity and prognosis of cardio-cerebrovascular diseases such as atherosclerosis (AS) and acute cerebral infarction (ACI). In conjunction with the traditional clinical diagnosis of acute coronary syndrome, it can be used as an early warning indicator for the recurrence of coronary artery disease or acute coronary syndrome.

The Finecare™ Lp-PLA2 Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of Lp-PLA2 in human serum, plasma or whole blood. The test is used as an aid to the assessment of the coronary heart disease (CHD) and ischemic stroke.

The Finecare™ Myo Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of Myoglobin in human whole blood, serum or plasma. This test is used as an aid to assist in the diagnosis of acute myocardial infarction (AMI).

The Finecare™ NT-proBNP Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) in human whole blood, serum or plasma. The test is used as an aid for the diagnosis of suspected congestive heart failure.

The Finecare™ One Step cTnT Rapid Quantitative Test along with Finecare™ FIA Meters is a fluorescence immunoassay for quantitative determination of cTnT concentration in human venous whole blood, serum or plasma specimen. It is mainly used as an aid to the diagnosis of myocardial infarction.